Business Overview
- Established ten years ago, the company is a rapidly growing organization within the pharmaceutical industry. With an extensive portfolio spanning allopathic, ayurvedic, and nutraceutical segments.
- Network of 20,000 doctors connected by 150 rep field force.
The top 5 brands are scaled across multiple states and have the potential to generate INR 100 Cr in sales in each.
- A total of 27 brands in the portfolio and trademarks for all brands.
- Top 4 brands have an average gross margin of 81%
- Top 5 brands have 51% of total revenues.
Long-term plans:
- Build a brand that is based on trust and consistency.
- Scale ethical product operations across 3 more states.
- Take OTC brands to every corner of India.
Products & Services Overview
Product portfolio:
1. Cough expectorant.
2. All-in-one cough management.
3. Pain management.
4. Indigestion reliever and appetite booster.
And 23 more brands which all have trademarks.
Capitalization Overview
- The business is currently funded by internal cashflows and bank loans.
- The company has bank loans and credit facilities of INR 2.5 Cr.
- The shareholding of the company is as follows:
- Promoter shareholding 75.29 %
- CXO team shareholding 15.05 %
- Other shareholders 9.66 %
Assets Overview
Stocks, brands and trademarks, passionate team of rep field force.
Full Sale
Asking Price:
USD
2.4 million
(Native Currency: INR 200,000,000)
Reason:
The decision to sell the company stems from a strategic consideration of succession planning. The ne...
View More
Includes physical assets worth
USD
120 thousand
Interested to connect with advisors
In talks with 3 Investors
Contact Business